+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review

PerkinElmer Inc (PKI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and various other services. The company’s major products include cytogenetic reagents, ELISA Kits, tissue biomarker reagents, atomic spectroscopy instruments, chromatography instruments, molecular spectroscopy, newborn screening instruments, and thermal analysis instruments. It offers reagents, instruments, assay platforms and software to hospitals, clinicians, medical labs and medical research professionals. PerkinElmer also offers cord blood and tissue banking, laboratory and research services. Its products are used in atomic spectroscopy, cell imaging and analysis, chromatography, analysis and detection, DNA/RNA isolation, in vivo imaging, molecular spectroscopy, protein analysis and detection, and tissue imaging, among others. The company operates in Asia-Pacific, Europe and North America. PerkinElmer is headquartered in Waltham, Massachusetts, the US.

PerkinElmer Inc Key Recent Developments

  • Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
  • Feb 27, 2023: PerkinElmer unveils multimode plate reader to expedite drug discovery
  • Feb 24, 2023: PerkinElmer launches EnVison Nexus multimode plate reader to drive improved research and discovery workflows
  • Nov 21, 2022: PerkinElmer helps accelerate gene therapy research with industry-first ready-to-use viral vector assays

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • PerkinElmer Inc - Key Facts
  • PerkinElmer Inc - Key Employees
  • PerkinElmer Inc - Key Employee Biographies
  • PerkinElmer Inc - Major Products and Services
  • PerkinElmer Inc - History
  • PerkinElmer Inc - Company Statement
  • PerkinElmer Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Section 2 - Company Analysis
  • Company Overview
  • PerkinElmer Inc - Business Description
  • Business Segment: Diagnostics
  • Overview
  • Performance
  • Key Stats
  • Business Segment: Discovery & Analytical Solutions
  • Overview
  • Performance
  • Key Stats
  • Geographical Segment: International
  • Target Markets
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • PerkinElmer Inc - Corporate Strategy
  • PerkinElmer Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • PerkinElmer Inc - Strengths
  • PerkinElmer Inc - Weaknesses
  • PerkinElmer Inc - Opportunities
  • PerkinElmer Inc - Threats
  • PerkinElmer Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • PerkinElmer Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • PerkinElmer Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Mar 09, 2023: PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
  • Feb 27, 2023: PerkinElmer unveils multimode plate reader to expedite drug discovery
  • Feb 24, 2023: PerkinElmer launches EnVison Nexus multimode plate reader to drive improved research and discovery workflows
  • Nov 21, 2022: PerkinElmer helps accelerate gene therapy research with industry-first ready-to-use viral vector assays
  • Nov 08, 2022: PerkinElmer Announces Financial Results for the Third Quarter of 2022
  • Oct 19, 2022: Medical Device Innovation Consortium (MDIC) partners with PerkinElmer's Horizon Discovery to improve accuracy of next generation sequencing-based cancer diagnostics
  • Oct 13, 2022: PerkinElmer Donation Helps Significantly Expand Capacity for Sickle Cell Disease Screening in Ghana
  • Sep 27, 2022: PerkinElmer launches Cellaca PLX image cytometry system
  • Sep 26, 2022: PerkinElmer unveils industry-first cell analysis solution to streamline cell and gene therapy research and manufacturing
  • Aug 17, 2022: PerkinElmer announces finance leadership transition
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • PerkinElmer Inc, Key Facts
  • PerkinElmer Inc, Key Employees
  • PerkinElmer Inc, Key Employee Biographies
  • PerkinElmer Inc, Major Products and Services
  • PerkinElmer Inc, History
  • PerkinElmer Inc, Other Locations
  • PerkinElmer Inc, Subsidiaries
  • PerkinElmer Inc, Joint Venture
  • PerkinElmer Inc, Key Competitors
  • PerkinElmer Inc, Ratios based on current share price
  • PerkinElmer Inc, Annual Ratios
  • PerkinElmer Inc, Interim Ratios
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • PerkinElmer Inc, Medical Equipment, Deals By Type, 2017 to YTD 2023
  • PerkinElmer Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • PerkinElmer Inc, Performance Chart (2018 - 2022)
  • PerkinElmer Inc, Ratio Charts
  • PerkinElmer Inc, Medical Equipment, Deals By Year, 2017 to YTD 2023
  • PerkinElmer Inc, Medical Equipment, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Shimadzu Corp
  • Beckman Coulter Inc
  • Harvard Bioscience Inc
  • Thermo Fisher Scientific Inc
  • MilliporeSigma
  • Precipio Inc
  • Spectris Plc
  • Bio-Rad Laboratories Inc